Page last updated: 2024-08-25

9-methylstreptimidone and Benign Neoplasms

9-methylstreptimidone has been researched along with Benign Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ishikawa, Y; Matsui, C; Nishiyama, S; Obata, R; Tachibana, M; Umezawa, K1
Umezawa, K1

Reviews

1 review(s) available for 9-methylstreptimidone and Benign Neoplasms

ArticleYear
[Screening of bioactive metabolites that suppress inflammation].
    Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme, 2007, Volume: 52, Issue:13 Suppl

    Topics: Animals; Anti-Inflammatory Agents; Benzamides; Biological Products; Cell Differentiation; Cyclohexanones; Depsipeptides; Drug Design; Drug Evaluation, Preclinical; Inflammation; Inflammation Mediators; Lipopolysaccharides; Neoplasms; NF-kappa B; Osteoclasts; Piperidones; Signal Transduction

2007

Other Studies

1 other study(ies) available for 9-methylstreptimidone and Benign Neoplasms

ArticleYear
Synthesis and biological evaluation on novel analogs of 9-methylstreptimidone, an inhibitor of NF-kappaB.
    Bioorganic & medicinal chemistry letters, 2009, Mar-15, Volume: 19, Issue:6

    Topics: Animals; Antioxidants; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Design; Humans; Inhibitory Concentration 50; Jurkat Cells; Lipopolysaccharides; Mice; Models, Chemical; Neoplasms; NF-kappa B; Nitric Oxide; Piperidones

2009